Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.
about
Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemicAntiretroviral therapy for prevention of HIV transmission in HIV-discordant couplesSocial marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender womenCombination prevention: new hope for stopping the epidemicPrevention of HIV-1 infection with early antiretroviral therapyAntiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosispeople who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan AfricaAntiretroviral therapy for prevention of HIV transmission: implications for EuropeProbing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological EvaluationHIV treatment as prevention: contradictory perspectives from dynamic mathematical modelsAntiretroviral prophylaxis for HIV prevention in heterosexual men and womenMorbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infectionTracking the evolution of HIV/AIDS in China from 1989-2009 to inform future prevention and control effortsMissed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in UgandaA complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategiesDevelopment and validation of a composite programmatic assessment tool for HIV therapyApplication and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, CanadaElimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison studyClosing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaHIV-1 diversity and drug resistance mutations among people seeking HIV diagnosis in voluntary counseling and testing sites in Rio de Janeiro, BrazilExpansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian settingA significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral loadRisk factors for delayed entrance into care after diagnosis among patients with late-stage HIV disease in southern VietnamThe Antiviral Activity of Approved and Novel Drugs against HIV-1 Mutations Evaluated under the Consideration of Dose-Response Curve SlopeSurveillance of HIV assisted partner services using routine health information systems in KenyaDeclines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, CanadaRetention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersRising population cost for treating people living with HIV in the UK, 1997-2013Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.HIV-1 Genetic Variability and Clinical ImplicationsChimeric Cyanovirin-MPER recombinantly engineered proteins cause cell-free virolysis of HIV-1.Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral loadIncreases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada.Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Can we trust the guidelines? Comparison between the data presented and the recommendations of the International Antiviral Society-USA PanelImpact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system.Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.HIV Risk Behaviors, Perceptions, and Testing and Preexposure Prophylaxis (PrEP) Awareness/Use in Grindr-Using Men Who Have Sex With Men in Atlanta, Georgia
P2860
Q21133704-B73599E9-599F-4AFD-8282-9E95B2441944Q24197939-6CA436EB-8BA4-4FB2-9DC9-C9E9A2C52FFFQ24234370-6D5123EA-6C09-4A96-8BA6-47720DAFB7AEQ24630559-A9FD1DDE-10BE-406F-AC9D-8C9BFBCB065AQ24634688-0DE81596-3640-4924-B6E5-B05415ECE5ECQ26825761-9F4E2D3C-3EFB-4709-97BA-8AF2B259E5B0Q26828443-F3C20F18-94D2-41FA-8CFA-A034B8CBCD36Q27021365-335C4DBB-7E5D-444B-B99D-CC67D3E320D6Q27023464-D027C3DF-73BB-4F64-81F3-D7BCE8932FCDQ27717366-5123A382-1FC7-4831-8D5D-640ECC0B3A9FQ28080917-9A7AB0F6-204F-4171-9AF2-0B7264E59A01Q28270788-BE31492E-0C24-428D-9411-2467414FB070Q28397243-F25C8313-EFDA-438A-B2CA-6439BF2194DCQ28477360-E60657EC-EE15-4FFB-95A6-CF62A5CF7B5BQ28478923-7735E8C4-7A6D-465E-99A8-9DF165343B1CQ28483747-8E643716-5FBF-44FF-88C7-F4DB22FD9824Q28485260-89E863D4-1866-4571-A88E-31B15E987C87Q28485334-3F21C0DB-936F-4A18-BF4E-5892B5BF4EB4Q28534568-1141539A-8FA2-43E6-9D81-E212079F3DC0Q28537704-6A92616F-2C1F-4883-8E4C-2F6C5782FA66Q28539348-339D0DC9-49CF-4272-9FEC-FB511FBA8E23Q28539721-1C68E3FD-6402-4C06-BC8F-5CDB387C3585Q28543626-AA94ED1C-36BD-4CDF-BDA1-A27E2037A12CQ28543860-4F5CE9F2-9A3A-4E03-9C1C-07D5408C6670Q28550441-671EA98C-A3E9-4794-8F7E-16032D7846CAQ28596036-805F29A8-0D21-4A8D-B741-3E6A5F6B608EQ28610686-4377B8DA-6B17-416D-B67E-75083D12EA85Q28729018-1CA816E2-8B19-4887-B797-B197C20AB3B2Q28743848-8B458F77-D120-499E-8509-5F4B344E65B1Q30248944-1E0C63C5-4F29-4320-8A06-D2ECE8AC8FB4Q30352010-64676CCA-769B-47F9-85C0-EEDECF080EEEQ30352110-B289D7E8-C12F-4FBE-8EDB-9D6F7B1E0C15Q30363571-B146686A-D1F1-4546-9ABE-51D7684BB7A9Q30363755-8C266D27-6002-40C4-9918-FC45F6926A5CQ30399058-BFABA12E-129C-4449-AAA0-67BCF2F85BA4Q30666487-7B718F41-E73D-4CB9-B9B7-903E91DA913DQ30869836-D8FFAF0C-B7CA-499E-A9E2-38C319480672Q30894245-CAA9EED3-8161-4DD8-8704-D3B1299B20EEQ31097026-ADBC0860-1334-48FD-ABD0-0B4A8FE1BE8EQ33446435-87AFE034-B55D-4717-BE2A-B3D051619E06
P2860
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of highly active a ...... ada: a population-based study.
@ast
Association of highly active a ...... ada: a population-based study.
@en
Association of highly active a ...... ada: a population-based study.
@nl
type
label
Association of highly active a ...... ada: a population-based study.
@ast
Association of highly active a ...... ada: a population-based study.
@en
Association of highly active a ...... ada: a population-based study.
@nl
prefLabel
Association of highly active a ...... ada: a population-based study.
@ast
Association of highly active a ...... ada: a population-based study.
@en
Association of highly active a ...... ada: a population-based study.
@nl
P2093
P2860
P50
P921
P1433
P1476
Association of highly active a ...... ada: a population-based study.
@en
P2093
Benita Yip
Kate Shannon
P Richard Harrigan
Perry Kendall
Rolando Barrios
Viviane D Lima
P2860
P304
P356
10.1016/S0140-6736(10)60936-1
P407
P577
2010-07-16T00:00:00Z